SEC FORM
3
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
| ONE NORTH SECOND ST |
| P O BOX 160 |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year)
04/21/2021
|
3. Issuer Name and Ticker or Trading Symbol
SONOCO PRODUCTS CO
[ SON ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
| X |
Officer (give title below) |
|
Other (specify below) |
| Corp Controller&PRIN Acct OFC |
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Common Stock |
1,019 |
D |
|
| Common Stock |
1,360 |
I |
By 401k |
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Restricted Stock Units |
02/10/2022 |
02/28/2024 |
Common Stock |
347 |
0.0000 |
D |
|
| Restricted Stock Units |
02/12/2022 |
02/28/2023 |
Common Stock |
63 |
0.0000 |
D |
|
| Restricted Stock Units |
02/13/2022 |
02/28/2022 |
Common Stock |
30 |
0.0000 |
D |
|
| Stock Appreciation Right |
02/10/2017 |
02/10/2026 |
Common Stock |
616 |
40.41 |
D |
|
| Stock Appreciation Right |
02/11/2016 |
02/11/2025 |
Common Stock |
389 |
46.16 |
D |
|
| Stock Appreciation Right |
02/14/2019 |
02/14/2028 |
Common Stock |
546 |
50.83 |
D |
|
| Stock Appreciation Right |
02/08/2018 |
02/08/2027 |
Common Stock |
395 |
54.46 |
D |
|
| Stock Appreciation Right |
02/13/2020 |
02/13/2029 |
Common Stock |
603 |
60.77 |
D |
|
| Explanation of Responses: |
| Remarks: |
|
|
By:Elizabeth R. Kremer-Power Attorney for James W. Kirkland |
04/30/2021 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Special Power of Attorney
Forms 3, 4 and 5 under the Securities
Exchange Act of 1934
KNOW ALL MEN BY THESE PRESENTS, that the undersigned director or
officer, or both, of Sonoco Products Company constitutes and appoints Julie C.
Albrecht, John M. Florence, Jr. and Elizabeth R. Kremer, his or her true and
lawful
attorneys-in-fact and agents with full power of substitution and resubstitution,
and each of them with full power to act without the other for him or her and in
his or her name, place and stead, in any and all capacities, to execute and
file, or cause to be filed, with the Securities and Exchange Commission Forms 3,
4 and 5 pursuant to Section 16 under the Securities Exchange Act of 1934, as
amended, (the "Act") and any amendment to the foregoing, on his or her behalf,
or on behalf of any trust or other entity that is required by the rules under
Section 16 of the Act, to file reports under Section 16 because of the fact that
said director or officer is a trustee, fiduciary or otherwise, granting unto
said attorneys-in-fact and agents, full power and authority to do and perform
each and every act and thing requisite and necessary to be done as fully to all
intents and purposes as he or she might or could do in person, hereby ratifying
and confirming all that said attorneys-in-fact and agents may lawfully do or
cause to be done by virtue hereof. The authority granted by this Special Power
of Attorney shall remain in effect as long as the undersigned is required to
file Forms 4 and 5 under the reporting requirements of Section 16. The
undersigned acknowledges that no attorney-in-fact of the undersigned pursuant to
this Special Power of Attorney, by serving in such capacity, is assuming any of
the undersigned's responsibilities to comply with Section 16 of the Act.
IN WITNESS WHEREOF, the undersigned has executed this Special Power of
Attorney this Twenty Seventh day of April, 2021.
Signature:__________________________
Typed: James W. Kirkland
